| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, December 2000, p. 3019-3035, Vol. 79, No. 6
*Departments of Medicine and Pediatrics, Duke University, Durham,
NC 27706, and
Department of Biometry, Medical
University of South Carolina, Charleston, SC 29426 USA
The role of inactivation as a central mechanism in
blockade of the cardiac Na+ channel by antiarrhythmic drugs
remains uncertain. We have used whole-cell and single channel
recordings to examine the block of wild-type and inactivation-deficient
mutant cardiac Na+ channels, IFM/QQQ, stably expressed in
HEK-293 cells. We studied the open-channel blockers disopyramide and
flecainide, and the lidocaine derivative RAD-243. All three drugs
blocked the wild-type Na+ channel in a use-dependent
manner. There was no use-dependent block of IFM/QQQ mutant channels
with trains of 20 40-ms pulses at 150-ms interpulse intervals during
disopyramide exposure. Flecainide and RAD-243 retained their
use-dependent blocking action and accelerated macroscopic current
relaxation. All three drugs reduced the mean open time of single
channels and increased the probability of their failure to open. From
the abbreviation of the mean open times, we estimated association rates
of ~106/M/s for the three drugs. Reducing the burst
duration contributed to the acceleration of macroscopic current
relaxation during exposure to flecainide and RAD-243. The qualitative
differences in use-dependent block appear to be the result of
differences in drug dissociation rate. The inactivation gate may play a
trapping role during exposure to some sodium channel blocking drugs.
Biophys J, December 2000, p. 3019-3035, Vol. 79, No. 6
© 2000 by the Biophysical Society 0006-3495/00/12/3019/17 $2.00
This article has been cited by other articles:
![]() |
Y. Zhu, J. W. Kyle, and P. J. Lee Flecainide sensitivity of a Na channel long QT mutation shows an open-channel blocking mechanism for use-dependent block Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H29 - H37. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Xiao, L. Ma, S.-Y. Wang, M. E. Josephson, G. K. Wang, J. P. Morgan, and A. Leaf Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids Am J Physiol Cell Physiol, February 1, 2006; 290(2): C362 - C370. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Wang, J. Mitchell, E. Moczydlowski, and G. K. Wang Block of Inactivation-deficient Na+ Channels by Local Anesthetics in Stably Transfected Mammalian Cells: Evidence for Drug Binding Along the Activation Pathway J. Gen. Physiol., November 29, 2004; 124(6): 691 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ramos and M. E O'Leary State-dependent trapping of flecainide in the cardiac sodium channel J. Physiol., October 1, 2004; 560(1): 37 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Desaphy, A. D. E. Luca, M. P. Didonna, A. L. George Jr, and D. C. Camerino Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block J. Physiol., January 15, 2004; 554(2): 321 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. O'Leary, M. Digregorio, and M. Chahine Closing and Inactivation Potentiate the Cocaethylene Inhibition of Cardiac Sodium Channels by Distinct Mechanisms Mol. Pharmacol., December 1, 2003; 64(6): 1575 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Wang, C. Russell, and S.-Y. Wang State-dependent Block of Wild-type and Inactivation-deficient Na+ Channels by Flecainide J. Gen. Physiol., August 25, 2003; 122(3): 365 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Wang, K. Bonner, C. Russell, and G. K. Wang Tryptophan Scanning of D1S6 and D4S6 C-Termini in Voltage-Gated Sodium Channels Biophys. J., August 1, 2003; 85(2): 911 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, M. Tateyama, C. E. Clancy, H. Abriel, and R. S. Kass Channel Openings Are Necessary but not Sufficient for Use-dependent Block of Cardiac Na+ Channels by Flecainide: Evidence from the Analysis of Disease-linked Mutations J. Gen. Physiol., June 24, 2002; 120(1): 39 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lee, A. Sunami, and H. A. Fozzard Cardiac-Specific External Paths for Lidocaine, Defined by Isoform-Specific Residues, Accelerate Recovery From Use-Dependent Block Circ. Res., November 23, 2001; 89(11): 1014 - 1021. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |